Janux Therapeutics (JANX) had the highest return in February 2024 by a mid-cap US stock, returning 456.1%.
Janux Therapeutics (JANX) had the highest return in February 2024 by a mid-cap US stock, returning 456.1%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.